- Home
- ITGR vs ZLAB Comparison
ITGR vs ZLAB Comparison
Compare ITGR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITGR | ZLAB |
|---|---|---|
| Founded | 1970 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ITGR | ZLAB |
|---|---|---|
| Price | $69.60 | $19.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $92.86 | $57.22 |
| AVG Volume (30 Days) | 623.1K | ★ 849.1K |
| Earning Date | 10-23-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $1,831,074,000.00 | $441,629,000.00 |
| Revenue This Year | $9.69 | $30.20 |
| Revenue Next Year | $0.48 | $34.71 |
| P/E Ratio | $28.71 | ★ N/A |
| Revenue Growth | 9.54 | ★ 24.14 |
| 52 Week Low | $62.00 | $19.40 |
| 52 Week High | $146.36 | $44.34 |
Technical Indicators
Market Signals| Indicator | ITGR | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 22.67 |
| Support Level | $69.40 | $19.40 |
| Resistance Level | $71.49 | $20.22 |
| Average True Range (ATR) | 1.63 | 0.52 |
| MACD | 1.00 | 0.22 |
| Stochastic Oscillator | 46.59 | 2.14 |
Price Performance
Historical ComparisonAbout ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.